Literature DB >> 31308021

Successful Treatment of Immune Checkpoint Inhibitor-Induced Diabetes With Infliximab.

Beckey Trinh1, Marc Y Donath2,3, Heinz Läubli3,4.   

Abstract

Entities:  

Year:  2019        PMID： 31308021     DOI： 10.2337/dc19-0908

Source DB:  PubMed          Journal:  Diabetes Care        ISSN： 0149-5992            Impact factor:   19.112


× No keyword cloud information.
  9 in total

Review 1.  Immune checkpoint inhibitor diabetes mellitus: a novel form of autoimmune diabetes.

Authors:  Z Quandt; A Young; M Anderson
Journal:  Clin Exp Immunol       Date:  2020-02-28       Impact factor: 4.330

Review 2.  Time to dissect the autoimmune etiology of cancer antibody immunotherapy.

Authors:  Michael Dougan; Massimo Pietropaolo
Journal:  J Clin Invest       Date:  2020-01-02       Impact factor: 14.808

Review 3.  Endocrine toxicities of immune checkpoint inhibitors.

Authors:  Jordan J Wright; Alvin C Powers; Douglas B Johnson
Journal:  Nat Rev Endocrinol       Date:  2021-04-19       Impact factor: 43.330

Review 4.  Adverse events induced by immune checkpoint inhibitors.

Authors:  Ana Luisa Perdigoto; Harriet Kluger; Kevan C Herold
Journal:  Curr Opin Immunol       Date:  2021-02-25       Impact factor: 7.486

Review 5.  Diabetes mellitus induced by immune checkpoint inhibitors: type 1 diabetes variant or new clinical entity? Review of the literature.

Authors:  V Lo Preiato; S Salvagni; C Ricci; A Ardizzoni; U Pagotto; C Pelusi
Journal:  Rev Endocr Metab Disord       Date:  2021-01-06       Impact factor: 6.514

6.  CANDIED: A Pan-Canadian Cohort of Immune Checkpoint Inhibitor-Induced Insulin-Dependent Diabetes Mellitus.

Authors:  Thiago P Muniz; Daniel V Araujo; Kerry J Savage; Tina Cheng; Moumita Saha; Xinni Song; Sabrina Gill; Jose G Monzon; Debjani Grenier; Sofia Genta; Michael J Allen; Diana P Arteaga; Samuel D Saibil; Marcus O Butler; Anna Spreafico; David Hogg
Journal:  Cancers (Basel)       Date:  2021-12-24       Impact factor: 6.639

Review 7.  Unravelling Checkpoint Inhibitor Associated Autoimmune Diabetes: From Bench to Bedside.

Authors:  Linda Wu; Venessa H M Tsang; Sarah C Sasson; Alexander M Menzies; Matteo S Carlino; David A Brown; Roderick Clifton-Bligh; Jenny E Gunton
Journal:  Front Endocrinol (Lausanne)       Date:  2021-11-05       Impact factor: 5.555

Review 8.  Gut Microbiota as a Trigger for Metabolic Inflammation in Obesity and Type 2 Diabetes.

Authors:  Torsten P M Scheithauer; Elena Rampanelli; Max Nieuwdorp; Bruce A Vallance; C Bruce Verchere; Daniël H van Raalte; Hilde Herrema
Journal:  Front Immunol       Date:  2020-10-16       Impact factor: 7.561

Review 9.  Current cancer therapies and their influence on glucose control.

Authors:  Carly Yim; Kerry Mansell; Nassrein Hussein; Terra Arnason
Journal:  World J Diabetes       Date:  2021-07-15
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.